Soleno Therap Drug Patent Portfolio

Soleno Therap's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Soleno Therap News

Neurocrine Acquires Soleno for $2.9 Billion, Potentially Securing Its Next Major Pharmaceutical Success

06 Apr, 2026

FDA Makes Announcement Regarding Replimune Following Developments from Sarepta and Soleno in the Biotechnology Industry

21 Aug, 2025

See More